|
Acquisition
Transasia Bio-Medicals Ltd Acquires European Diagnostic Company
Plans to invest more than $1 million in Lachema to increase
manufacturing capacities and add new products
Suresh Vazirani |
Transasia Bio-Medicals Ltd, India's largest clinical diagnostic
company, has acquired Pliva Lachema Diagnostika, a 42-year-old company located
in Czech Republic. PLIVA Lachema Diagnostika is engaged in the development,
production and marketing of in vitro diagnostics products consisting of a range
for urine analysis, biochemistry and microbiology.
The company, with its extensive marketing and distribution network in the countries
of Central and Eastern Europe adequately complements the current market potential
and product lines of Transasia and Erba Mannheim. It has state-of-the-art manufacturing
and Research & Development facilities at Brno, employing over 100 people.
Said Suresh Vazirani, MD, Transasia, "The acquisition
by Transasia through its German subsidiary ERBA Diagnostics Mannheim GmbH, provides
a great opportunity for Transasia and ERBA to usher in newer products in the
dynamically developing markets of Asia. Also, Lachema's customers in Central
and Eastern Europe will have access to Transasia's extensive product range in
clinical chemistry, immunoturbidimetry and immunology." Transasia and ERBA
Diagnostics Mannheim plan to invest more than $1 million in Lachema to increase
its manufacturing capacities and add new products in the near future for meeting
growing demand.
"This new acquisition greatly expands the spectrum of technologically-advanced
products and manufacturing capabilities of Transasia. Transasia and ERBA customers
will now benefit with these products being offered at high quality and affordable
prices," he added.
This acquisition now allows Transasia customers access to
a wide range of solutions for microbiology and usher in a quicker and better
diagnosis for a range of health issues, which is great news for the Indian healthcare
scene. This acquisition will augment the company's vision of bringing benefits
of the best diagnostic technologies within reach for its vast populations in
developing countries. The company is a partner of the Clinton Foundations Aids
Control Programme in Africa and India.
Transasia and its 100 per cent German subsidiary, ERBA Diagnostics Mannheim
GmbH, has a distribution network spread over 55 countries worldwide, in markets
like Italy, Germany, France, Australia, China, Turkey, Latin America, Africa,
Russia, Middle East, SAARC and Asia.
EH News Bureau
|
